Meghmani Organics Limited (MOL) AI Stock Analysis

3 Followers

Meghmani Organics Limited

(NSE:MOL)

Select Model

Rating:71Outperform

Price Target:INR 61.00▲(9.95% Upside)

Action:upgraded

Date:08/25/26

The overall score of 71 is led by powerful technical momentum and a vital turnaround in free cash flow and net income. While the stock's bullish trend indicates strong market enthusiasm, historically thin profit margins, a low return on equity, and an average valuation profile slightly restrain the stock's fundamental strength.

Positive Factors

Earnings and cash-flow recoveryThe return to positive earnings and free cash flow in 2026 provides a stronger internal funding base than the prior loss-making period. If maintained, improved cash conversion can support operations and reduce reliance on external financing over the next several quarters.

Negative Factors

Thin profitabilityVery thin operating and net margins leave limited room for cost increases, pricing pressure, or weaker demand before earnings are affected. This reduces the company’s earnings cushion and makes sustained profitability more difficult than the 2026 recovery alone suggests.

Meghmani Organics Limited (MOL) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 14.12B
Dividend Yield: ―
Average Volume (3M): 89.16K
Price to Earnings (P/E): 16.3
Beta (1Y): 1.35
Revenue Growth: -5.19%
EPS Growth: 118.24%
Country: India
Employees: 1,154
Sector: General
Sector Strength: 55
Industry: Agricultural Inputs

Meghmani Organics Limited Business Overview & Revenue Model

Company Description

Meghmani Organics Limited, founded in 1986 and headquartered in Ahmedabad, India, operates as a producer and supplier of an extensive range of pigments and agrochemical products, catering to markets both within India and globally. The company's pigme...

Meghmani Organics Limited Financial Statement Overview

Summary

Financial performance reflects a recovering profile with a return to profitability and 975 million in positive free cash flow, though this is tempered by historically thin profit margins and a weak return on equity of 1.86%.

Income Statement

56Neutral

Balance Sheet

68Positive

Cash Flow

72Positive

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	21.93B	21.74B	21.24B	15.48B	25.28B	24.73B
Gross Profit	6.82B	5.93B	8.60B	4.44B	9.30B	9.41B
EBITDA	2.93B	2.73B	1.87B	119.50M	4.10B	4.81B
Net Income	865.79M	287.39M	-106.01M	-1.06B	2.38B	3.04B
Balance Sheet
Total Assets	31.94B	30.21B	30.85B	30.40B	31.98B	27.98B
Cash, Cash Equivalents and Short-Term Investments	175.56M	264.88M	227.24M	330.74M	1.52B	117.22M
Total Debt	6.64B	7.26B	8.29B	8.37B	8.24B	4.99B
Total Liabilities	15.66B	14.76B	15.70B	15.12B	15.29B	13.31B
Stockholders Equity	16.27B	15.45B	15.15B	15.28B	16.69B	14.66B
Cash Flow
Free Cash Flow	0	975.10M	-226.88M	-165.29M	-2.61B	-1.79B
Operating Cash Flow	0	1.43B	662.22M	2.50B	2.04B	648.32M
Investing Cash Flow	0	-458.42M	309.70M	-1.78B	-4.18B	-1.33B
Financing Cash Flow	0	-1.04B	-913.88M	-854.77M	2.34B	577.19M

Meghmani Organics Limited Technical Analysis

Technical Analysis SentimentPositive

Last Price55.48

Price Trends

50DMA58.39Negative

100DMA56.21Negative

200DMA53.38Positive

Market Momentum

MACD-0.74Negative

RSI48.71Neutral

STOCH49.31Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MOL, the sentiment is Positive. The current price of 55.48 is above the 20-day moving average (MA) of 54.91, below the 50-day MA of 58.39, and above the 200-day MA of 53.38, indicating a neutral trend. The MACD of -0.74 indicates Negative momentum. The RSI at 48.71 is Neutral, neither overbought nor oversold. The STOCH value of 49.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:MOL.

Meghmani Organics Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:MOL against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:DHANUKA	73Outperform	INR 40.27B	14.51	―	0.22%	-0.06%	0.75%
IN:SHARDACROP	71Outperform	INR 65.69B	10.24	―	2.06%	17.28%	42.45%
IN:MOL	71Outperform	INR 14.11B	16.28	―	―	-5.19%	118.24%
IN:PIIND	58Neutral	INR 260.17B	29.63	―	0.58%	-14.95%	-41.96%
IN:UPL	58Neutral	INR 468.51B	25.01	―	1.08%	10.33%	-14.32%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:IPL	51Neutral	INR 13.73B	14.51	―	0.63%	2.89%	-9.47%

* General Sector Average

Performance Comparison

IN:MOL and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:MOL	Meghmani Organics Limited	55.48	-16.73	-23.17%
IN:DHANUKA	Dhanuka Agritech Limited	903.45	-365.10	-28.78%
IN:IPL	India Pesticides Ltd.	119.20	-59.68	-33.37%
IN:PIIND	PI Industries Limited	1714.80	-1809.19	-51.34%
IN:SHARDACROP	Sharda Cropchem Ltd.	728.15	-53.22	-6.81%
IN:UPL	UPL Limited	555.00	-210.39	-27.49%

Meghmani Organics Limited Corporate Events

Meghmani Organics Announces 7th AGM and E-Voting Arrangements

Aug 15, 2026

Meghmani Organics Limited has notified the stock exchanges that it has published newspaper advertisements announcing its seventh Annual General Meeting for the financial year 2025-26. The AGM will be conducted via video conferencing or other audio-vi...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 25, 2026

Meghmani Organics Limited AI Stock Analysis